Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CFTR modulators: transformative therapies for cystic fibrosis.

Journal of managed care & specialty pharmacy - 1 Feb 2021

Dwight Mary, Marshall Bruce

Abstract excerpt

DISCLOSURES: No funding contributed to the writing of this commentary. Both authors are employed by the Cystic Fibrosis Foundation. The Cystic Fibrosis Foundation has entered into therapeutic development award agreements and licensing agreements to assist with the development of CFTR modulators that may result in intellectual property rights, royalties, and other forms of consideration provided to CFF. Some of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aminophenols
Share to Benzodioxoles
Share to Chloride Channel Agonists

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Approval

Share to Drug Costs

Share to Quinolines

Share to Quinolones

Share to United States Food and Drug Administration

Source

Open in PubMed Open full text

Identifiers

PMID: 33506726
DOI: 10.18553/jmcp.2021.27.2.281
PMCID: PMC10391283

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CFTR modulators: transformative therapies for cystic fibrosis.PMID 33506726Read ↗

Discovery of CFTR modulators for the treatment of cystic fibrosis.Semantic proximity Read ↗

CFTR Modulators: Shedding Light on Precision Medicine for Cystic FibrosisSemantic proximity Read ↗

CFTR Modulators: From Mechanism to Targeted Therapeutics.Semantic proximity Read ↗

Emerging medicines to improve the basic defect in cystic fibrosis.Semantic proximity Read ↗

An update on new and emerging therapies for cystic fibrosis.Semantic proximity Read ↗

CFTR modulator therapy: transforming the landscape of clinical care in cystic fibrosis.Semantic proximity Read ↗

Advances in the diagnosis and treatment of cystic fibrosis.Semantic proximity Read ↗

CFTR dysfunction and targeted therapies: A vision from non-cystic fibrosis bronchiectasis and COPD.Semantic proximity Read ↗

Emerging drugs for cystic fibrosisSemantic proximity Read ↗

Targeted therapy for cystic fibrosisSemantic proximity Read ↗

Pulmonology: CFTR modulators for cystic fibrosis.Semantic proximity Read ↗

CFTR potentiators: not an open and shut case.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.